discovery of PRN1008, a BTK inhibitor - drug annotations
Автор: Chem Help ASAP
Загружено: 2022-05-27
Просмотров: 594
Описание:
directory of Chem Help ASAP videos: https://www.chemhelpasap.com/youtube/
link to J. Med. Chem. article: https://pubs.acs.org/doi/10.1021/acs....
This video describes the discovery of PRN1008, an inhibitor of Bruton's tyrosine kinase (BTK), a kinase targeted for oncology, immunology, and inflammation indications. The content of this video was reported by scientists at Principia Biopharma, a subsidiary of Sanofi, in South San Franciso, CA as a Drug Annotations article in the Journal of Medicinal Chemistry. The discovery started with ibrutinib, a known BTK inhibitor, and modified the tether between the scaffold of the drug followed by the functionality of the Michael acceptor. PRN1008 incorporated a distinctive cyanoacrylamide that allowed reversible, covalent inhibition of BTK. PRN1008 has advanced into clinical trials for the treatment of both pemphigus vulgaris and immune thrombocytopenia.
This video was created for academic purposes. The creator of the video has no financial stake in Principia Biopharma or Sanofi.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: